Prostate HistoScanning: a screening tool for prostate cancer?

Area of Science:

• Urology
• Medical Imaging
• Oncology

Background:

• Prostate cancer screening relies on digital rectal examination and prostate-specific antigen (PSA) levels, which can lead to unnecessary biopsies.
• Accurate identification of men requiring prostate biopsy is crucial to improve diagnostic yield and patient outcomes.

Purpose of the Study:

• To evaluate Prostate HistoScanning as a pilot screening tool for prostate cancer.
• To assess the efficacy of HistoScanning in guiding prostate biopsies and improving cancer detection.

Main Methods:

• A pilot study involving 94 men with abnormal screening parameters examined using Prostate HistoScanning.
• 41 men underwent prostate biopsy guided by computer-aided ultrasonography based on HistoScanning analysis.
• Logistic regression analysis used to correlate HistoScanning findings with positive biopsy results.

Main Results:

• An increase in cancer volume by 1 mL, as estimated by HistoScanning, was associated with a nearly threefold increase in the probability of a positive biopsy (OR 2.9, P=0.02).
• Prostate cancer was detected in 41% (17 of 41) of biopsied men.
• HistoScanning-guided biopsies demonstrated a 4.5-fold higher cancer detection rate compared to random biopsies (58% vs 13%) and significantly reduced the number of biopsies needed (P<0.0001).

Conclusions:

• Prostate HistoScanning may aid in selecting patients who require prostate biopsies.
• This imaging technique enhances cancer detection rates by directing biopsies to suspicious prostatic regions.